RxSight's market cap is currently $346.97M. The company's EPS TTM is $-0.29; its P/E ratio is ―; RxSight is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
